Ergoteles’s CryoPort CYRX Stock Holding History

Ergoteles’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,222	Closed	-$322K	–	1542
2022 Q3	$322K	Buy	+13,222	New	+$455K	0.01%	947
2021 Q3	–	Sell	-5,800	Closed	-$366K	–	1307
2021 Q2	$366K	Buy	+5,800	New	+$326K	0.01%	965
2021 Q1	–	Sell	-19,700	Closed	-$864K	–	845
2020 Q4	$864K	Buy	+19,700	New	+$938K	0.03%	356

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Ergoteles's CYRX Position: Q4 2022 in Review

Ergoteles sold out of CryoPort (CYRX) in Q4 2022, closing a stake of 13,222 shares — an estimated $322K sold.

Ergoteles first reported a position in CYRX in Q4 2020 and held it in 3 quarters. The position peaked at $864K in Q4 2020. 171 funds tracked by Wall St. Rank hold CYRX as of Q4 2022.

Ergoteles reported no remaining CryoPort position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 13,222 CryoPort shares in Q4 2022, an estimated $322K.
Ergoteles first reported a position in CryoPort in Q4 2020 and held it in 3 quarters.
Ergoteles's CryoPort position peaked at $864K in Q4 2020.
171 funds tracked by Wall St. Rank held CryoPort as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.